How much funding has CranioSense raised?

CranioSense has raised $5.7M in total funding, most recently a Grant round.

When was CranioSense founded?

CranioSense was founded in 2024.

Where is CranioSense headquartered?

CranioSense is headquartered in Bedford, Massachusetts, United States.

What industry is CranioSense in?

CranioSense operates in Healthcare, Digital Health, Medical Devices.

How many employees does CranioSense have?

CranioSense has 1-10 employees.

CranioSense

Q: Who are CranioSense's investors?

CranioSense's investors include NIH Blueprint MedTech, U.S. Department of Defense, Heinz Ventures.

Noninvasive brain pressure monitoring, anywhere it's needed

Bedford, United States · Founded 2024 · $5.7M raised

Healthcare

Digital Health

Medical Devices

Headquarters: Bedford, Massachusetts
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: craniosense.com
Total Funding: $5.7M
Last Round: $5.5M GrantDec 2025
Rounds: 2

About

CranioSense is a clinical-stage medtech company developing IPASS, a noninvasive intracranial pressure monitoring device that measures ICP in seconds using a forehead patch and handheld sensors — no skull drilling required. The company targets traumatic brain injury, ICU, and emergency care settings where current invasive ICP methods are too risky to use broadly. CranioSense was awarded $5.5M in NIH and DoD federal grants in late 2024.

Summary

CranioSense is a Healthcare company based in Bedford, United States, founded in 2024. It has raised $5.7M in total across 2 rounds, most recently a $5.5M Grant round in Dec 2025. Investors include NIH Blueprint MedTech, U.S. Department of Defense and Heinz Ventures.